SAC Capital Advisors LP - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 143 filers reported holding CLOVIS ONCOLOGY INC in Q2 2014. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
SAC Capital Advisors LP ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q1 2014$31,742,000
-54.9%
458,238
-60.7%
0.16%
-59.6%
Q4 2013$70,317,000
+6.4%
1,166,700
+7.3%
0.41%
+14.0%
Q3 2013$66,091,000
+42.2%
1,087,375
+56.7%
0.36%
+40.4%
Q2 2013$46,466,000693,7290.26%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q2 2014
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$45,630,648,00043.63%
EcoR1 Capital, LLC 384,348$21,523,00010.89%
Palo Alto Investors LP 2,102,857$117,760,0006.91%
NEA Management Company, LLC 2,279,781$127,668,0006.19%
Redmile Group, LLC 721,632$40,411,0004.40%
Opaleye Management Inc. 140,000$7,840,0003.96%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 790,555$44,271,0002.63%
SUFFOLK CAPITAL MANAGEMENT LLC 339,327$19,002,0002.31%
PFM Health Sciences, LP 1,725,126$96,607,0002.26%
HARBOURVEST PARTNERS LLC 51,037$2,858,0001.50%
View complete list of CLOVIS ONCOLOGY INC shareholders